Coloplast A/S - Announcement no
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Coloplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22

Coloplast is a purpose-driven company: We make life easier for people living with intimate healthcare needs. In 2021/22, we continued to help more than two million users globally, but many user needs remain unmet across our business areas. We strive to build better standards of care, raise the bar with innovative products and create access for as many users as possible. We are building the consumer healthcare company of the future – enabling self-care for chronic users and supporting healthcare systems to meet, in a cost-effective way, increasing demand as the world population ages. This is a direct embodiment of the Coloplast mission and our key contribution to sustainable development.

As part of our corporate strategy, Strive25, we have made it a clear priority to grow our business in a sustainable way. We focus on improving our products and packaging and reducing our emissions while always operating responsibly. To deliver on our 2025 ambitions, we are investing up to DKK 250 million during the strategy period.

During FY 2021/22, Coloplast made progress on key ambitions, including welcoming 250,000 new patients into the Coloplast® Care programme, increasing the recycling rate of production waste to 71% (up from 58% in 2020/21) and reducing our scope 1 and 2 emissions by 8% since the base year 2018/19.

Please find our Sustainability Report 2021/22 on the link below.

Our mission
Making life easier for people
with intimate health care needs

Our values
Closeness... to better understand
Passion... to make a difference
Respect and responsibility... to guide us

Our vision
Setting the global standard
for listening and responding
  

For further information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Aleksandra Dimovska
Director, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: [email protected]

Kristine Husted Munk
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 3266
Email: [email protected]

Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: [email protected] 

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice and Respiratory Care. We operate globally and employ more than 14,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-11.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment


Nyheter om Coloplast

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Coloplast

Senaste nytt